Molecular Cancer Research Targeting the PI3-Kinase Pathway in Cancer Bridging the Lab and the Clinic in Cancer Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huang, D. C.
Right arrow Articles by Kremer, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huang, D. C.
Right arrow Articles by Kremer, R.
Molecular Cancer Research 1:56-67 (2002)
© 2002 American Association for Cancer Research


Signaling and Regulation

Targeted Disruption of the 25-Hydroxyvitamin D3 1{alpha}-Hydroxylase Gene in ras-Transformed Keratinocytes Demonstrates That Locally Produced 1{alpha},25-Dihydroxyvitamin D3 Suppresses Growth and Induces Differentiation in an Autocrine Fashion1

Dao Chao Huang1, Vasilios Papavasiliou1, Johng S. Rhim2, Ronald L. Horst3 and Richard Kremer1

1 Department of Medicine, Royal Victoria Hospital and McGill University, Montreal, Quebec, Canada;
2 Center for Prostate Disease Research, Uniformed Services, University of the Health Sciences, Bethesda, MD; and
3 USDA, Agriculture Research Service, National Animal Disease Center, Ames, IA

Requests for reprints: Richard Kremer, Room H4.67, Calcium Research Laboratory, Royal Victoria Hospital, 687 Pine Avenue West, Montreal, Quebec, H3A 1A1 Canada. Phone: (514) 843-1632; Fax: (514) 843-1712.

It has been previously shown that keratinocytes express a high level of 25-hydroxyvitamin D3 (25-OHD3) 1{alpha}-hydroxylase (1{alpha}-hydroxylase). 1{alpha}-Hydroxylase catalyzes the conversion of 25-OHD3 to 1{alpha},25-dihydroxyvitamin D3 [1,25(OH)2D3]. 1,25(OH)2D3 is both antiproliferative (i.e., suppresses cell growth) and prodifferentiative (i.e., induces cell differentiation) in many cell types. We hypothesized that local production of 1,25(OH)2D3 by keratinocytes may suppress their growth and induce their differentiation in an autocrine fashion. To test this hypothesis, we inactivated both 1{alpha}-hydroxylase alleles in a ras-transformed keratinocyte cell line, HPK1Aras, which typically produces squamous carcinoma in nude mice. To inactivate 1{alpha}-hydroxylase expression by HPK1Aras cells, we disrupted both alleles of the 1{alpha}-hydroxylase gene by homologous recombination. Lack of expression and activity of 1{alpha}-hydroxylase was confirmed by Northern blot analysis and detected conversion of 25-OHD3 to 1,25(OH)2D3. We then examined the effect of substrate 25-OHD3 on parameters of growth and differentiation in the double knockout cell line as compared to wild-type HPK1Aras cells in vitro. It was found that 1{alpha}-hydroxylase inactivation blocked the antiproliferative and prodifferentiative effect of 25-OHD3. These in vitro effects were further analyzed in vivo by injecting knockout or control cells subcutaneously in severely compromised immunodeficient mice. Tumor growth was accelerated and differentiation was inhibited in mice given injections of knockout cells as compared to control cells in the presence of substrate 25-OHD3. Our results demonstrate, for the first time, that 1{alpha}-hydroxylase expression by keratinocytes plays an important role in autocrine growth and differentiation of these cells, and suggest that expression of this enzyme may modulate tumor growth in squamous carcinomas.

Key Words: cancer • vitamin D • knockout • keratinocytes • 1{alpha}-hydroxylase




This article has been cited by other articles:


Home page
J. Nutr.Home page
C. M. Kemmis, S. M. Salvador, K. M. Smith, and J. Welsh
Human Mammary Epithelial Cells Express CYP27B1 and Are Growth Inhibited by 25-Hydroxyvitamin D-3, the Major Circulating Form of Vitamin D-3
J. Nutr., April 1, 2006; 136(4): 887 - 892.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. S. Dusso, A. J. Brown, and E. Slatopolsky
Vitamin D
Am J Physiol Renal Physiol, July 1, 2005; 289(1): F8 - F28.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
G. G. Schwartz, D. Eads, A. Rao, S. D. Cramer, M. C. Willingham, T. C. Chen, D. P. Jamieson, L. Wang, K. L. Burnstein, M. F. Holick, et al.
Pancreatic cancer cells express 25-hydroxyvitamin D-1{alpha}-hydroxylase and their proliferation is inhibited by the prohormone 25-hydroxyvitamin D3
Carcinogenesis, June 1, 2004; 25(6): 1015 - 1026.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.